Drug class
Type I interferon Receptor Antagonist; Type I Interferon Receptor Antagonist
Mechanism of action
Type I Interferon Receptor Antagonists [MoA]
General use cases
- Lupus Vasculitis, Central Nervous System
- adult patients with moderate to severe systemic lupus erythematosus (SLE), who are receiving standard therapy
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
